MedutestMaison d'Analyse · Genève
✓

Authentic report — verified

This certificate was issued by Medutest and matches our records. Reference ID confirmed.

Product
Oritavancin Peptide Core
Specification
97.5% · 500mg
Report Type
Sterility / USP <71>
Catalogue
GL-PP-0045
Issued
2026-02-06
Oritavancin Peptide Core Sterility / USP <71> report by Medutest
↓ Download report Visit Medutest
Verification reference: 31748-Oritavancin_Peptide_Core_500mg_SYJ9L3R4BLGE